АМБУЛАТОРИЯ ШАРОИТИДА КЕНГ ТАРҚАЛГАН УРОЛОГИК КАСАЛЛИКЛАРНИ ЭРТА АНИҚЛАШГА МЎЛЖАЛЛАНГАН ДИХОТОМИК СКРИНИНГ СЎРОВНОМАСИНИНГ МАЗМУН ВАЛИДЛИГИНИ БАҲОЛАШ
Kalit so‘zlar:
мазмун валидлиги, урологик касалликлар, скрининг сўровномаси, валидация, амбулатор диагностикаAbstrak
Тадқиқотнинг мақсади амбулатория шароитида кенг тарқалган урологик касалликларни эрта аниқлашга мўлжалланган дихотомик скрининг сўровномасининг мазмун валидлигини баҳолашдан иборат эди. Валидацияда 8 нафар эксперт-уролог иштирок этди. Сўровноманинг якуний версиясидаги 120 та савол тўрт балли шкала бўйича баҳоланди; Lynn ҳамда Polit ва Beck тавсиялари асосида I-CVI, S-CVI/Ave ва S-CVI/UA ҳисобланди. S-CVI/Ave = 1,00 (≥ 0,90), S-CVI/UA = 1,00 (≥ 0,80), барча 120 та савол учун I-CVI = 1,00 бўлди. Экспертлар баҳоларининг айнан бир хил бўлиши 90,8% саволда қайд этилди. Сўровнома мезоний ва конструкт валидлигини баҳолашнинг кейинги босқичларига тайёр
##plugins.themes.default.displayStats.downloads##
Havolalar
1. Liu Q., Yang S., Zhang H., et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Military Medical Research. 2024;11:64. DOI: 10.1186/s40779-024-00569-w.
2. Parsons J.K., Dadam S.Y., Sarma A.B. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Translational Andrology and Urology. 2013;2(3):130–140. DOI: 10.3978/j.issn.2223-4683.2013.08.01.
3. Metzler I., Bayne D., Chang H., et al. Challenges facing the urologist in low- and middle-income countries. World Journal of Urology. 2020;38:2987–2994. DOI: 10.1007/s00345-020-03191-4.
4. Chu H., Wang D.C., Xie H., et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Military Medical Research. 2021;8(1):64. DOI: 10.1186/s40779-021-00359-8.
5. Barry M.J., Fowler F.J., O’Leary M.P., et al. The American Urological Association symptom index for benign prostatic hyperplasia. Journal of Urology. 1992;148(5):1549–1557. DOI: 10.1016/s0022-5347(17)36966-5.
6. Homma Y., Yoshida M., Seki N., et al. Symptom assessment tool for overactive bladder syndrome - overactive bladder symptom score. Urology. 2006;68(2):318–323. DOI: 10.1016/j.urology.2006.02.042.
7. Litwin M.S., McNaughton-Collins M., Fowler F.J., et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Journal of Urology. 1999;162(2):369–375. DOI: 10.1016/S0022-5347(05)68562-X.
8. Tsang S., Royse C.F., Terkawi A.S. Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi Journal of Anaesthesia. 2017;11(Suppl 1):S80–S89. DOI: 10.4103/sja.SJA_203_17.
9. Lawshe C.H. A quantitative approach to content validity. Personnel Psychology. 1975;28(4):563–575. DOI: 10.1111/j.1744-6570.1975.tb01393.x.
10. Lynn M.R. Determination and quantification of content validity. Nursing Research. 1986;35(6):382–385. DOI: 10.1097/00006199-198611000-00017.
11. Polit D.F., Beck C.T. The content validity index: are you sure you know what’s being reported? Critique and recommendations. Research in Nursing & Health. 2006;29(5):489–497. DOI: 10.1002/nur.20147.
12. Polit D.F., Beck C.T., Owen S.V. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Research in Nursing & Health. 2007;30(4):459–467. DOI: 10.1002/nur.20199.
13. Almanasreh E., Moles R., Chen T.F. Evaluation of methods used for estimating content validity. Research in Social and Administrative Pharmacy. 2019;15(2):214–221. DOI: 10.1016/j.sapharm.2018.03.066.
14. Souza A.C., Alexandre N.M.C., Guirardello E.B. Psychometric properties in instruments evaluation of reliability and validity. Epidemiologia e Serviços de Saúde. 2017;26(3):649–659. DOI: 10.5123/S1679-49742017000300022.
15. Yilmaz V., Arslan D. Content validity in measurement scales: a literature review. Eurasian Journal of Educational Research. 2019;19(84):85–102. DOI: 10.14689/ejer.2019.84.5.
16. Rodrigues I.B., Adachi J.D., Beattie K.A., et al. Measurement properties of patient-reported outcome questionnaires in urology: a systematic review. Urology. 2017;99:41–48. DOI: 10.1016/j.urology.2016.08.063.
17. Ayre C., Scally A.J. Critical values for Lawshe’s content validity ratio: revisiting the original methods of calculation. Measurement and Evaluation in Counseling and Development. 2014;47(1):79–86. DOI: 10.1177/0748175613513808.
